Nov 6 (Reuters) – Dental health company vVardis said on Friday it was targeting a valuation of up to $4.37 billion in its US initial public offering.
The company is seeking to raise up to $228.6 million by offering 9.5 million shares priced between $21 and $24 each.
Goldman Sachs, J.P. Morgan, William Blair, UBS Investment Bank and Deutsche Bank Securities are the underwriters for the offering.
vVardis plans to list its shares on the NYSE under the symbol “VVVV.”
(Reporting by Prakhar Srivastava in Bengaluru; Editing by Jonathan Ananda)
